Stockreport

Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout [Yahoo! Finance]

SOPHiA GENETICS SA - Ordinary Shares  (SOPH) 
PDF Powered by the Swiss data company's genomic analysis platform, SOPHiA DDM, MSK-ACCESS is a decentralised version of a liquid biopsy test developed by the Memorial Sloan [Read more]